GlaxoSmithKline Biologicals

Grantee website Rixensart, Antwerpen, Belgium
Purpose
to accelerate Ebola Vaccine Production and Development order to treat those affected by the Ebola epidemic in West Africa
Division
Global Development
Date
OCTOBER 2014
Region served
AFRICA
Committed amount
$1,281,469
Grant topic
Emergency Response
Duration (months)
26
Grantee location
Rixensart, Antwerpen, Belgium

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.